1. Home
  2. CLDI vs GP Comparison

CLDI vs GP Comparison

Compare CLDI & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • GP
  • Stock Information
  • Founded
  • CLDI 2014
  • GP 2010
  • Country
  • CLDI United States
  • GP Canada
  • Employees
  • CLDI N/A
  • GP N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • CLDI Health Care
  • GP Consumer Discretionary
  • Exchange
  • CLDI Nasdaq
  • GP Nasdaq
  • Market Cap
  • CLDI 14.0M
  • GP 12.7M
  • IPO Year
  • CLDI N/A
  • GP 2020
  • Fundamental
  • Price
  • CLDI $0.48
  • GP $0.43
  • Analyst Decision
  • CLDI Strong Buy
  • GP Strong Buy
  • Analyst Count
  • CLDI 2
  • GP 2
  • Target Price
  • CLDI $15.00
  • GP $2.33
  • AVG Volume (30 Days)
  • CLDI 386.9K
  • GP 63.5K
  • Earning Date
  • CLDI 05-13-2025
  • GP 02-14-2025
  • Dividend Yield
  • CLDI N/A
  • GP N/A
  • EPS Growth
  • CLDI N/A
  • GP N/A
  • EPS
  • CLDI N/A
  • GP N/A
  • Revenue
  • CLDI N/A
  • GP $20,656,035.00
  • Revenue This Year
  • CLDI N/A
  • GP N/A
  • Revenue Next Year
  • CLDI N/A
  • GP $94.25
  • P/E Ratio
  • CLDI N/A
  • GP N/A
  • Revenue Growth
  • CLDI N/A
  • GP N/A
  • 52 Week Low
  • CLDI $0.35
  • GP $0.41
  • 52 Week High
  • CLDI $4.90
  • GP $1.91
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 38.44
  • GP 39.45
  • Support Level
  • CLDI $0.41
  • GP $0.42
  • Resistance Level
  • CLDI $0.45
  • GP $0.45
  • Average True Range (ATR)
  • CLDI 0.07
  • GP 0.04
  • MACD
  • CLDI 0.02
  • GP 0.00
  • Stochastic Oscillator
  • CLDI 56.57
  • GP 25.56

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: